Clinical Trials Directory

Trials / Completed

CompletedNCT01762982

Patch Test of Benzalkonium Chloride Disinfectant Spray

A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the irritation potential of benzalkonium chloride disinfectant spray when placed in contact with normal human skin.

Detailed description

Benzalkonium chloride is recognized as safe and effective for short term use as first aid antiseptic drug products. In this study, benzalkonium chloride disinfectant spray will be compared to a positive control, and two negative control for irritancy potential on normal skin according to Chinese Patch Test Guideline (China Health Authority 2002). The skin irritation assessment will characterize the test products individually in terms of symptomatology using a 5-point categorical scale ranging from 0 (no visible reaction) to 4 (Erythema,edema˛ extreme blistering).

Conditions

Interventions

TypeNameDescription
DRUG0.13% Benzalkonium ChlorideFinn Chamber filled with benzalkonium chloride (0.13%) disinfectant spray water solution
DRUGSLS SolutionFinn Chamber filled with SLS (0.3% w/v) water solution
DRUGNormal Saline WaterFinn Chamber filled with Normal Saline water (0.9% w/v)
OTHEREmpty Finn ChamberEmpty Finn Chamber

Timeline

Start date
2012-02-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2013-01-08
Last updated
2014-01-22
Results posted
2014-01-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01762982. Inclusion in this directory is not an endorsement.